RTU manufacturing carries more value - and more responsibility.
Ready-to-use cartridge manufacturers are taking on a critical role in biopharmaceutical supply chains. By supplying cartridges already washed, depyrogenated, siliconized, assembled, packaged and sterile, they enable pharma companies to outsource container preparation and the associated validation burden.
With the injectable-drug market projected to expand 1.9×, rising volumes intensify the challenge: RTU manufacturers are therefore carrying more value and more responsibility providing complete documentation for customer qualification.
An RTU manufacturer must demonstrate sterility while preserving every attribute required for customer qualification and release: from closure integrity and gliding performance to particulate control, seal strength, printing and dryness.
Our capabilities on RTU cartridges and syringes demonstrated the required sterility without adversely affecting container-closure integrity, break-loose and glide performance or particulate levels. The results confirmed that closure functionality and baked-on siliconization remained intact, with no increase in fibres generated by the Tyvek® lid or packaging.
The outcome is a customer-ready RTU system, backed by documented evidence and proven for repeatable industrial-scale production.
saturated-steam cycles are developed around the complete cartridge, nest, tub and sterile-barrier configuration
H₂O₂ treats thermosensitive configurations through controlled vacuum, vapour delivery, temperature management and aeration, according to material compatibility and packaging permeability.
Preserving functionality through moist-heat sterilization.
Saturated-steam cycles are developed around the complete cartridge, nest, tub and sterile-barrier configuration. Effective air removal and steam penetration establish the required thermal exposure, while modulated transitions between vacuum and overpressure protect Tyvek® positioning and sealing width. Controlled drying supports packaging integrity and final release.
An alternative for thermosensitive configurations.
For configurations that cannot tolerate heat and moisture, H₂O₂ provides a low-temperature alternative when material compatibility, packaging permeability and microbial-reduction requirements support its use. Controlled vacuum removes trapped air and facilitates vapour penetration through the sterile barrier, while temperature management prevents condensation. Defined exposure and final aeration support microbial effectiveness and residual removal without compromising the complete packaged system.
The automated manipulator connects treatment and point of use through controlled loading, unloading, movement and delivery operations. Depending on the selected route, it handles canisters, sterile tanks or treated materials and manages their interface with the isolator or filling line. Automation removes avoidable manual interventions precisely where exposure, repeated handling and open connections create the greatest vulnerability.
Before sterile processing can begin, reusable aluminium kegs are washed to remove manufacturing residues and prepare every product-contact surface for downstream depyrogenation. Washing represents the first operation of the production campaign, creating consistent starting conditions for sterile container preparation while supporting repeatable processing of every batch of reusable primary containers.
Tyvek® bags provide a sterile barrier while allowing steam penetration, but processing machine parts inside porous packaging — particularly in double-bag configurations — introduces challenges that cannot be managed by temperature alone.
Irregular geometries, different thermal masses, folds, overlapping surfaces and contact with the trays influence air removal, steam circulation and condensate evacuation. At the same time, rapid pressure changes can mechanically stress the bags, while poorly controlled depressurization can cool the load and make drying more difficult.
3
functional attributes preserved: container-closure integrity, break-loose and glide performance, and particulate levels were not adversely affected by the steam-sterilization process
0
adverse shift in the mean values or distribution of break-loose and glide forces, confirming preserved baked-on siliconization functionality
0
particulate increase detected: no increase in fibres or particles generated by the tyvek® lid or packaging after moist-heat sterilization.
0
CCI failures confirming that the thermal process preserved closure performance.
Yes. Both families present siliconized glass surfaces, assembled components, nested packaging and pressure-sensitive sterile barriers. This experience strengthens process understanding, but each cartridge configuration remains independently developed and validated because its geometry, components and load arrangement are specific.
Capacity is engineered across the complete system. Automated transfer reduces handling time, while upstream preheating or conditioning and validated downstream drying, conditioning or aeration release the main chamber earlier. This increases effective output without relying only on a larger sterilizer.
The equipment controls chamber and load temperature throughout conditioning, injection and exposure. Maintaining the required temperature margin supports homogeneous vapour distribution and prevents condensation that could compromise penetration, material compatibility or residual removal.
The sterilant does not interact with the cartridge alone. Nest density, tub geometry, porous lids, protective bags and load arrangement influence air removal or vapour access, exposure, condensate formation, drying and aeration. The complete configuration must therefore be treated as one defined load.
Saturated steam is selected when the complete cartridge and packaging configuration tolerates heat and moisture. Low-temperature H₂O₂ is selected for thermosensitive configurations with compatible materials and permeable sterile-barrier packaging. The two routes are not automatically interchangeable: the complete commercial system must be tested and validated.
An unsuitable process can affect packaging, assembled components or siliconized surfaces. Development must demonstrate microbial effectiveness together with preservation of the relevant functional attributes. Sterility is not sufficient if the cartridge no longer performs as specified during filling or administration.
Knowledge Hub Regulatory
Read this article
